Tremor, stiffness or slowness of movements have always been the major symptoms while diagnosing Parkinson’s disease. However, when you begin observing these symptoms, it’s often too late with the regards to the disease progress, as it has already caused significant damage to the brain.
There’s more to just the symptoms established earlier. If one wishes to identify the diseases at an early stage loss of smell, difficulties in sleeping can be some of the changes which are considered as the early symptoms of Parkinson’s disease. Additionally, cognition changes, condition run in the family in the past, head injury play a crucial role in determining the early symptoms of the disease.
The talks around early symptoms have made it to the research papers. Though there’s a still blur picture of the early phase, researchers are going to down to the wire to gain an in-depth view of the early symptoms. Diagnosing the Parkinson’s disease before it establishes in the body has raised hopes for successful treatment to be found. The present medical solutions essentially reduce disease symptoms. However, do not stop its progression.
The recent medical research reports have observed significant understanding of factors which affect and increases the risks of Parkinson’s disease for a person. Researchers presently are conducting a study of the UK population with more than 60 years of age. This is anticipated to take Parkinson’s symptoms study ahead for further development in the treatments.
If the researchers succeeded in comprehending who can have more risks of getting Parkinson’s disease, it will be easier to develop treatments for the disease in its early stages. In fact, medical research can go long enough to discover the preventive measures of the disease. If this happens, this will be a major leap in the brain healthcare world. Besides, this could play a role in the treatments of dementia and other brain diseases.
The research which is presently being conducted in the UK involves a quick questionnaire. The participants are asked to send a sample of his/her saliva while undergoing a small ‘scratch and sniff’ examination. A part of this is then sent for further tests.
The impact of clinical trials:
There remains a huge pressure on the researchers for finding the accurate treatments of Parkinson’s disease. Not only the research can bring about better treatments, but it will also mitigate the pressure of finding a solution for the disease. Developments and favourable discoveries in early symptom detection research will be a crunch point for clinical trials.
Though not a victim of Parkinson’s disease, people contributing to the study conducted can view better healthcare solutions around and a world no more Parkinson’s-afraid. Researchers are planning to employ the test results in an algorithm which can project people’s risks of the long-feared disease.
Parkinson’s disease tops the list after Alzheimer’s in neurodegenerative diseases. The number of people becoming Parkinson’s disease victims is increasing like ever before in the neurological conditions. New findings bring hope in the people. It will be interesting to see what the new research reports reveal about the early symptoms of Parkinson’s disease and impacts the neuro-healthcare world.